Guangxi Medical University

This Phase 3 trial tests whether giving a targeted chemotherapy treatment (TACE) after liver cancer surgery can prevent the cancer from coming back. It involves 442 patients with high-risk features for recurrence. Half will receive TACE, and the other half will have intensive mon…

This study is testing whether an artificial intelligence (AI) model can accurately predict which prostate cancers are aggressive and need treatment. Researchers will combine MRI and ultrasound images with tissue samples from 3,000 men. The goal is to reduce unnecessary biopsies a…

This trial compares a new surgery called partial stomach-partitioning gastrojejunostomy (SPGJ) to the standard surgery for relieving stomach blockage in advanced gastric cancer. The goal is to see which surgery better helps patients eat normally, with fewer complications like del…

This study looks back at the medical records of 2000 people with liver cancer in Guangxi, China. Researchers want to find out which treatments given before surgery (called conversion or neoadjuvant therapy) work best to help patients live longer. The study includes treatments lik…